ursodeoxycholic acid

It is used to dissolve cholesterol gallstones (of appropriate size and X-ray radiolucency), in the treatment of reflux gastritis, in the treatment of primary biliary cirrhosis, and in children and adolescents for the treatment of liver disorders associated with cystic fibrosis.

Form: capsules, hard

ATC: A05AA02

Manufacturer: APL Swift Services (Malta) Ltd., Generis Farmaceutica S.A.

The medicine is used to dissolve gallstones (up to 15 mm in diameter, radiolucent and composed of cholesterol), in the treatment of primary biliary cirrhosis, and in the treatment of liver disease in children (from 6 to 18 years old) resulting from cystic fibrosis.

Form: tablets, film-coated

ATC: A05AA02

Manufacturer: PRO.MED.CS Praha a.s.

It is used to dissolve gallstones (up to 15 mm in diameter, radiolucent and composed of cholesterol), in the treatment of primary biliary cirrhosis, and in children and adolescents with liver problems resulting from cystic fibrosis.

Form: tablets, film-coated

ATC: A05AA02

Manufacturer: PRO.MED.CS. Praha s.a.

The medicine is used to dissolve cholesterol gallstones (up to 15 mm in diameter), in the treatment of primary biliary cirrhosis, in cases of intrahepatic cholestasis in pregnant women, in the treatment of gastritis caused by bile reflux, in other liver and biliary tract diseases, and in the treatment of liver dysfunction related to cystic fibrosis in children and adolescents.

Form: tablets

ATC: A05AA02

Manufacturer: Polfarmex S.A.

The medicine is used to dissolve cholesterol gallstones in the gallbladder (in patients for whom surgery is not possible), for the symptomatic treatment of primary biliary cholangitis, and for the treatment of liver disorders in children with cystic fibrosis.

Form: capsules

ATC: A05AA02

Manufacturer: Dr. Falk Pharma GmbH

The medicine is used to dissolve cholesterol gallstones in the gallbladder (in patients who cannot undergo surgery), in the treatment of primary biliary cholangitis, and in the case of liver disorders in children with cystic fibrosis.

Form: suspension, oral

ATC: A05AA02

Manufacturer: Dr. Falk Pharma GmbH

The medicine is used to dissolve cholesterol gallstones in the gallbladder (in patients who cannot undergo surgery), in the treatment of primary biliary cholangitis, and in the treatment of liver disorders in children (aged 6–18 years) due to cystic fibrosis.

Form: tablets, film-coated

ATC: A05AA02

Manufacturer: Dr. Falk Pharma GmbH

The medicinal product is used to dissolve cholesterol gallstones (of appropriate size and structure), in the treatment of liver and biliary tract diseases (including primary biliary cirrhosis and cholestasis in pregnant women), in the treatment of gastritis caused by bile reflux, and in the prevention of gallstones in patients after bariatric surgery or rapid weight loss.

Form: capsules, hard

ATC: A05AA02

Manufacturer: ICN Polfa Rzeszów S.A.

The medicine is used to dissolve cholesterol gallstones (up to 15 mm in diameter), in the treatment of primary biliary cirrhosis, and other liver and bile duct diseases. It also helps in the treatment of gastritis caused by bile reflux, in cases of intrahepatic cholestasis in pregnant women, and in the prevention of gallstones in individuals following bariatric surgery or rapid weight loss.

Form: capsules, hard

ATC: A05AA02

Manufacturer: Bausch Health Poland Sp. z o.o.

Ursoxyn is used to dissolve cholesterol gallstones (in patients for whom surgery is not an option and who have normal gallbladder function), in the treatment of primary biliary cirrhosis, and in the treatment of liver diseases resulting from cystic fibrosis in children and adolescents. It is also used before and after extracorporeal shock wave lithotripsy for kidney stones.

Form: capsules, hard

ATC: A05AA02

Manufacturer: AS Grindeks